2002
DOI: 10.1207/s15327914nc4402_02
|View full text |Cite
|
Sign up to set email alerts
|

A Meta-Analysis of Published Literature on Waist-to-Hip Ratio and Risk of Breast Cancer

Abstract: Epidemiological studies have identified body weight as a risk factor for breast cancer. Beyond the amount of adipose tissue a woman has, its distribution, particularly abdominally, may be a risk factor in breast cancer etiology. Body fat distribution is commonly measured by a waist-to-hip circumference ratio lpar;WHR). We performed a meta-analysis to summarize the published literature on WHR and breast cancer risk. After assembling all published studies, we extracted mean WHRs for study participants and adjust… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
91
0
1

Year Published

2005
2005
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 136 publications
(95 citation statements)
references
References 50 publications
3
91
0
1
Order By: Relevance
“…2,3,12,13,14 Our results of a decrease in risk of premenopausal breast cancer with increasing thorax and waist circumferences are in agreement with previous studies. 2,12,15 The decrease in risk observed with increasing WHR is in disagreement with past studies and reviews, 3,6,12,[15][16][17] which found a possible increase in risk of premenopausal breast cancer with increasing WHR. The highest increase in risk was observed in Männistö's analysis of a case-control study, with an RR of 4.6 (2.0-10.7) for women with a WHR greater than 0.87 compared with those with a WHR less than 0.78.…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…2,3,12,13,14 Our results of a decrease in risk of premenopausal breast cancer with increasing thorax and waist circumferences are in agreement with previous studies. 2,12,15 The decrease in risk observed with increasing WHR is in disagreement with past studies and reviews, 3,6,12,[15][16][17] which found a possible increase in risk of premenopausal breast cancer with increasing WHR. The highest increase in risk was observed in Männistö's analysis of a case-control study, with an RR of 4.6 (2.0-10.7) for women with a WHR greater than 0.87 compared with those with a WHR less than 0.78.…”
Section: Discussionmentioning
confidence: 55%
“…5 However, most studies on these indices 4 have produced conflicting results and although abdominal obesity is likely to be positively related to postmenopausal breast cancer, it seems not to be predictive of premenopausal breast cancer risk. In a recent meta-analysis, 6 an increase in breast cancer risk was associated with abdominal obesity, assessed by WHR, irrespective of menopausal status.…”
Section: Introductionmentioning
confidence: 99%
“…It is widely accepted that being overweight, traditionally defined as having a body mass index (BMI; obtained by dividing the individual's weight in kilograms by height in metres squared) 425 kg/m 2 , is a major risk factor for a wide range of chronic diseases and injuries including cardiovascular disease (CVD), type II diabetes, and certain sitespecific cancers including colorectal and breast cancer (Connolly et al, 2002;Chouraki et al 2008). A recent report from the Prospective Studies Collaboration, which was based on 466 000 deaths, estimated that optimal survival is achieved at a BMI of 22.5-25 kg/m 2 with reductions in life expectancy of 3 and 10 years in individuals with moderate (BMI 30-35 kg/m 2 ) and extreme obesity (BMI 40-50 kg/m 2 ), respectively, the latter being equivalent to the years lost by lifetime smoking (Prospective Studies Collaboration, 2009).…”
Section: Introductionmentioning
confidence: 99%
“…Several studies have suggested a direct association between components of metabolic syndrome and BC risk (Xue and Michels, 2007;Vona-Davis et al, 2007;Rosato et al, 2011). Therefore, low HDL-cholesterol (Furberg et al, 2004), high blood glucose (Muti et al, 2002), high triglycerides (Potischman et al, 1991), postmenopausal overweight (World Cancer Research Fund, 2007), abdominal obesity (Connolly et al, 2002), hypertension (Soler et al, 1999), high levels of insulin (Hirose et al, 2003), C peptide (Verheus et al, 2006), and insulin-like growth factor I (IGF-I) (Campagnoli et al, 2008), have all been associated with increased BC risk. Metabolic and hormonal factors related to metabolic syndrome have also been implicated in BC prognosis (Goodwin et al, 2002;Rock et al, 2002;Pasanisi et al, 2006;Agnoli et al, 2010;Tsugane and Inoue, 2010).…”
Section: Introductionmentioning
confidence: 99%